SE392902B - Forfarande for framstellning av fenylimidazolidinoner - Google Patents
Forfarande for framstellning av fenylimidazolidinonerInfo
- Publication number
- SE392902B SE392902B SE7207420A SE742072A SE392902B SE 392902 B SE392902 B SE 392902B SE 7207420 A SE7207420 A SE 7207420A SE 742072 A SE742072 A SE 742072A SE 392902 B SE392902 B SE 392902B
- Authority
- SE
- Sweden
- Prior art keywords
- phenylimidazolidinones
- procedure
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT492071A AT311956B (de) | 1971-06-07 | 1971-06-07 | Verfahren zur Herstellung neuer Phenylimidazolidinonderivate und ihrer Salze |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE392902B true SE392902B (sv) | 1977-04-25 |
Family
ID=3569889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7207420A SE392902B (sv) | 1971-06-07 | 1972-06-06 | Forfarande for framstellning av fenylimidazolidinoner |
Country Status (20)
| Country | Link |
|---|---|
| AR (7) | AR200112A1 (sv) |
| AT (1) | AT311956B (sv) |
| AU (1) | AU473287B2 (sv) |
| BE (1) | BE784475A (sv) |
| BG (1) | BG22822A3 (sv) |
| CA (1) | CA1011336A (sv) |
| CH (7) | CH591475A5 (sv) |
| DD (1) | DD101403A5 (sv) |
| DE (1) | DE2223751A1 (sv) |
| ES (1) | ES403542A1 (sv) |
| FR (1) | FR2140492B1 (sv) |
| GB (1) | GB1391491A (sv) |
| HU (1) | HU165493B (sv) |
| IE (1) | IE37812B1 (sv) |
| IL (1) | IL39620A (sv) |
| NL (1) | NL7207701A (sv) |
| NO (1) | NO136841C (sv) |
| SE (1) | SE392902B (sv) |
| SU (8) | SU493067A3 (sv) |
| ZA (1) | ZA723840B (sv) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19822678A1 (de) * | 1998-05-20 | 1999-11-25 | Bayer Ag | Substituierte 1,3-Diaza-2-(thi)oxo-cycloalkane |
| CA2568607A1 (en) * | 2003-05-28 | 2004-12-09 | Imotep Inc. | Haloethyl urea compounds and the use thereof to attenuate, inhibit or prevent cancer cell migration |
| CA2568609A1 (en) * | 2003-05-28 | 2004-12-09 | Imotep Inc. | Haloethyl urea compounds and their use to attenuate, inhibit or prevent non-cancerous pathogenic cellular proliferation and diseases associated therewith |
| RU2497810C1 (ru) * | 2012-06-28 | 2013-11-10 | Общество с ограниченной ответственностью "Объединенный центр исследований и разработок" | Способ получения n,n-диарилзамещенных 2-трихлорометилимидазолидинов |
-
1971
- 1971-06-07 AT AT492071A patent/AT311956B/de not_active IP Right Cessation
-
1972
- 1972-05-16 DE DE19722223751 patent/DE2223751A1/de active Pending
- 1972-05-31 SU SU1970169A patent/SU493067A3/ru active
- 1972-05-31 SU SU1791532A patent/SU453839A3/ru active
- 1972-06-05 CA CA143,854A patent/CA1011336A/en not_active Expired
- 1972-06-05 BG BG020655A patent/BG22822A3/xx unknown
- 1972-06-06 CH CH1507275A patent/CH591475A5/xx not_active IP Right Cessation
- 1972-06-06 IL IL39620A patent/IL39620A/en unknown
- 1972-06-06 BE BE784475A patent/BE784475A/xx unknown
- 1972-06-06 NO NO2007/72A patent/NO136841C/no unknown
- 1972-06-06 CH CH840072A patent/CH573425A5/xx not_active IP Right Cessation
- 1972-06-06 FR FR7220319A patent/FR2140492B1/fr not_active Expired
- 1972-06-06 HU HUBO1379A patent/HU165493B/hu unknown
- 1972-06-06 ES ES403542A patent/ES403542A1/es not_active Expired
- 1972-06-06 CH CH1507175A patent/CH583729A5/xx not_active IP Right Cessation
- 1972-06-06 SE SE7207420A patent/SE392902B/sv unknown
- 1972-06-06 CH CH1507475A patent/CH589644A5/xx not_active IP Right Cessation
- 1972-06-06 DD DD163478A patent/DD101403A5/xx unknown
- 1972-06-06 CH CH1507675A patent/CH589646A5/xx not_active IP Right Cessation
- 1972-06-06 CH CH1507375A patent/CH590269A5/xx not_active IP Right Cessation
- 1972-06-06 CH CH1507575A patent/CH589645A5/xx not_active IP Right Cessation
- 1972-06-06 AU AU43129/72A patent/AU473287B2/en not_active Expired
- 1972-06-06 ZA ZA723840A patent/ZA723840B/xx unknown
- 1972-06-07 NL NL7207701A patent/NL7207701A/xx unknown
- 1972-06-07 GB GB2662372A patent/GB1391491A/en not_active Expired
- 1972-06-07 IE IE791/72A patent/IE37812B1/xx unknown
- 1972-06-07 AR AR242433A patent/AR200112A1/es active
-
1973
- 1973-01-01 AR AR249758A patent/AR205522A1/es active
- 1973-01-01 AR AR249754A patent/AR207109A1/es active
- 1973-08-24 AR AR249753A patent/AR203017A1/es active
- 1973-08-24 AR AR249755A patent/AR202904A1/es active
- 1973-08-24 AR AR249757A patent/AR200139A1/es active
- 1973-08-24 AR AR249752A patent/AR202903A1/es active
- 1973-11-14 SU SU1970242A patent/SU509228A3/ru active
- 1973-11-14 SU SU1970167A patent/SU505358A3/ru active
- 1973-11-14 SU SU1970170A patent/SU498907A3/ru active
- 1973-11-14 SU SU1970171A patent/SU492085A3/ru active
- 1973-11-14 SU SU1970168A patent/SU503516A3/ru active
- 1973-11-14 SU SU1970164A patent/SU499806A3/ru active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE392269B (sv) | Forfarande for framstellning av vissa indanyloxitetrazoler | |
| SE398877B (sv) | Forfarande for framstellning av 14-hydroxi-morfinanderivat | |
| SE411755B (sv) | Forfarande for framstellning av n-substituerade 1-aminometylindaner | |
| SE400292B (sv) | Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat | |
| NO147916C (no) | Fremgangsmaate for fremstilling av 3-metylen-cefalosporin-forbindelser. | |
| SE390633B (sv) | Forfarande for framstellning av ethambutol | |
| SE417200B (sv) | Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat | |
| SE400764B (sv) | Forfarande for framstellning av substituerade 3-hydroximetylisokinoliner | |
| SE393615B (sv) | Forfarande for framstellning av 6-metyl-8 beta-ureidometyl-ergolener | |
| SE405478B (sv) | Forfarande for framstellning av alfa-sulfoacylcefalosporiner | |
| SE397090B (sv) | Forfarande for framstellning av hydroxipyrimidiner | |
| SE384686B (sv) | Forfarande for framstellning av linkomycinderivat | |
| SE380815B (sv) | Forfarande for framstellning av transparenta sampolyamider | |
| SE391332B (sv) | Forfarande for framstellning av en fenyletanolamin | |
| SE412756B (sv) | Alternativa forfarande for framstellning av 2-(aminofenylimino)-3-aza-1-tia-cykloalkaner | |
| SE408177B (sv) | Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat | |
| SE387936B (sv) | Forfarande for framstellning av substituerade metoxiaminer | |
| SE382985B (sv) | Forfarande for framstellning av oxazoler | |
| SE380520B (sv) | Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin | |
| SE398123B (sv) | Forfarande for framstellning av metoximetylestern av hetacillin | |
| SE392902B (sv) | Forfarande for framstellning av fenylimidazolidinoner | |
| SE386897B (sv) | Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler | |
| SE405730B (sv) | Forfarande for framstellning av kinazolinderivat | |
| SE397350B (sv) | Forfarande for framstellning av tieno-diazepinderivat | |
| SE387948B (sv) | Forfarande for framstellning av tiofen |